These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17448041)

  • 1. The new concept of periodontal disease pathogenesis requires new and novel therapeutic strategies.
    Taubman MA; Kawai T; Han X
    J Clin Periodontol; 2007 May; 34(5):367-9. PubMed ID: 17448041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response: the key to bone resorption in periodontal disease.
    Taubman MA; Valverde P; Han X; Kawai T
    J Periodontol; 2005 Nov; 76(11 Suppl):2033-41. PubMed ID: 16277573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis.
    Mogi M; Otogoto J; Ota N; Togari A
    J Dent Res; 2004 Feb; 83(2):166-9. PubMed ID: 14742657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.
    Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Atilla G; Hughes FJ; Belibasakis GN
    J Clin Periodontol; 2007 May; 34(5):370-6. PubMed ID: 17355365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RANKL-OPG system in clinical periodontology.
    Belibasakis GN; Bostanci N
    J Clin Periodontol; 2012 Mar; 39(3):239-48. PubMed ID: 22092994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis.
    Giannopoulou C; Martinelli-Klay CP; Lombardi T
    Acta Odontol Scand; 2012 Dec; 70(6):629-34. PubMed ID: 22214279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and bone loss in periodontal disease.
    Cochran DL
    J Periodontol; 2008 Aug; 79(8 Suppl):1569-76. PubMed ID: 18673012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total oxidant status and bone resorption biomarkers in serum and gingival crevicular fluid of patients with periodontitis.
    Baltacıoğlu E; Kehribar MA; Yuva P; Alver A; Atagün OS; Karabulut E; Akalın FA
    J Periodontol; 2014 Feb; 85(2):317-26. PubMed ID: 23701481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyromonas gingivalis infection-associated periodontal bone resorption is dependent on receptor activator of NF-κB ligand.
    Han X; Lin X; Yu X; Lin J; Kawai T; LaRosa KB; Taubman MA
    Infect Immun; 2013 May; 81(5):1502-9. PubMed ID: 23439308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
    Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
    J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of periodontal treatment on the RANKL/OPG ratio in crevicular fluid.
    López Roldán A; García Giménez JL; Alpiste Illueca F
    PLoS One; 2020; 15(1):e0227757. PubMed ID: 31986169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging roles of Interleukin-34 together with receptor activator of nuclear factor-kB ligand and osteoprotegerin levels in periodontal disease.
    Bozkurt Doğan Ş; Öngöz Dede F; Ballı U; Sertoğlu E
    Cytokine; 2021 Aug; 144():155584. PubMed ID: 34034144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-based assay strategy for identification of motif-specific RANK signaling pathway inhibitors.
    Chen T; Feng X
    Assay Drug Dev Technol; 2006 Aug; 4(4):473-82. PubMed ID: 16945019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial-responsive B lymphocytes induce periodontal bone resorption.
    Han X; Kawai T; Eastcott JW; Taubman MA
    J Immunol; 2006 Jan; 176(1):625-31. PubMed ID: 16365458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RANK/RANKL/OPG triad in cancer-induced bone diseases.
    Dougall WC; Chaisson M
    Cancer Metastasis Rev; 2006 Dec; 25(4):541-9. PubMed ID: 17180711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of chitosan oligosaccharide on alveolar bone resorption, Th17/Treg balance and OPG/RANKL/RANK pathway in periodontitis rats].
    Zhang L; Liu YS; Wu YF; Fu QY
    Shanghai Kou Qiang Yi Xue; 2021 Jun; 30(3):237-242. PubMed ID: 34476437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).
    Liu W; Zhang X
    Mol Med Rep; 2015 May; 11(5):3212-8. PubMed ID: 25572286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of periodontal treatment on receptor activator of NF-κB ligand and osteoprotegerin levels and relative ratio in gingival crevicular fluid.
    Bostanci N; Saygan B; Emingil G; Atilla G; Belibasakis GN
    J Clin Periodontol; 2011 May; 38(5):428-33. PubMed ID: 21261673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gingival crevicular fluid levels of SLIT3 are increased in periodontal disease.
    Zhong W; Peng Y; Yue E; Huang B; Zhang W; Zhao Z; Jiang J; Wang Q; Zhao H
    Oral Dis; 2020 Jan; 26(1):182-192. PubMed ID: 31696592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RANKL upregulation associated with periodontitis and Porphyromonas gingivalis.
    Wara-aswapati N; Surarit R; Chayasadom A; Boch JA; Pitiphat W
    J Periodontol; 2007 Jun; 78(6):1062-9. PubMed ID: 17539720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.